Evaluation of the Effects Using the Combination of Sedative Agents on Dental Anxiety in Pediatric Patients

Anxiety Postoperative Clinical Trial

Official title:

Çocuk Hastalarda Değişik Konsantrasyonlarda Kullanılan Sedasyon Ajanlarının Anksiyete Üzerine Etkilerinin Değerlendirilmesi

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04623970
• Other study ID #: 82/2
• Status: Completed
• Phase: N/A
• Start date: November 28, 2018
• Est. completion date: October 5, 2020

Study information

• Verified date: November 2020
• Source: Cukurova University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aims of this study were firstly, to evaluate the changes in the anxiety level after deep sedation with various intravenous sedative agents using salivary cortisol level in pediatric dental patients and secondly, to compare clinical effectiveness of this sedative agents, perioperative complications, recovery time and adverse effects.

Description:

This clinical study was included 69 healthy pediatric patients aged 3 to 7 years with high anxiety. The patients were divided into 3 groups according to the sedative agents: Group 1 (n=23) was received Propofol, Group 2 (n=23) was receieved Ketofol 1:3, and Group 3 (n=23) was received Ketofol 1:4. The anxiety levels were assessed using Facial Image Scale (FIS) anxiety scale and changes in salivary cortisol levels were assessed using ELISA before and after the drug administration. Perioperative vital signs, depth of sedation were recorded at intervals of 5 minutes. Preoperative and postoperative complications, operation and recovery time were recorded in the follow-up form.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 69
• Est. completion date: October 5, 2020
• Est. primary completion date: January 23, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 3 Years to 7 Years

Eligibility

Inclusion Criteria:

• Pediatric patients age between 3-7 years old

• Having no systemic condition and ASA 1 healty status

• Having high dental anxiety

• Having no dental treatment under the sedation or general anesthesia before

• Having no dental treatment before

Exclusion Criteria:

• Having obstructed nasal passages, raised intracranial or intraocular pressure, allergy

• Using any drug which effected saliva construction

• Having enough saliva for saliva cortisol evaluation

Related Conditions & MeSH terms

• Anxiety Disorders
• Anxiety Postoperative

Intervention

Procedure:
• Dental Treatment
Comprehensive dental care (restorative treatmen, crowns, pulp therapy, fissure sealant and teeth extraction for pediatric patients under the deep sedation

Locations

Country	Name	City	State
Turkey	Cukurova University	Adana

Sponsors (1)

Lead Sponsor	Collaborator
Cukurova University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Dental anxiety (subjective)	Units on a Scale (Patient's dental anxiety level was evaluated with Facial Image Scale after treatment. Patients signed from 1 to 5 score for dental anxiety.The data were collected and statistically analysed using by the numerical data. In this study, "1" and "2" scores are considered as better outcome. Patients who signed these scores described as no anxiety. The worst outcome is considered as the patients signed "4-5". Each scale range for each time interval evaluated as count of patient and presented as percentage.)	through study completion, an average of 12 months
Primary	Dental anxiety (objective)	Units on Saliva cortisol levels (Dental anxiety was evaluated with Enzyme-linked immunosorbent assay after treatment.The patients were measured from 0 to 200 nmol/L for dental anxiety after the treatment.The data were collected and statistically analysed using by the numerical data. In this study, " 0-28 nmol/L'' are considered as better outcome. Patients who were have these scores described no dental anxiety for deep sedation. The worst outcome is considered as the anxious patients have ">28 nmol/L ". Each value range for each time interval evaluated as count of patient and presented as percentage.)	through study completion, an average of 12 months
Primary	Depth of sedation	Units on a Scale (Depth of sedation was evaluated with Ramsay Sedation Scale during the sedation. Observer signed from 0 to 5 score for depth of sedation during the treatment.The data were collected and statistically analysed using by the numerical data. In this study, "4-5" scores are considered as better outcome. Patients who were signed these scores described as sedated patients for dental treatment. The worst outcome is considered as the patients signed "0-3". Each scale range for each time interval evaluated as count of patient and presented as percentage.)	through study completion, an average of 12 months
Primary	Postperative complications	Units on a Scale ( Postoperative complications were evaluated with a form which was included absence or presence of agitation, hypersalivation, nausea-vomiting and double vision. Observer signed absence or presence for each complications after the treatment.The data were collected and statistically analysed using by the numerical data)	through study completion, an average of 12 months
Primary	Perioperative complications	Units on a Scale (Perioperative complications were evaluated with a form which was included absence or presence of local injection pain, cough, saturation drop and spontaneous movement. Observer signed absence or presence for each perioperative complications during the deep sedation.The data were collected and statistically analysed using by the numerical data)	through study completion, an average of 12 months
Secondary	Heart Rate	Differents Units of measure (Heart rate beats in bpm was measured per five minutes during the operation)	through study completion, an average of 12 months
Secondary	Systolic and diastolic arterial pressure	Differents Units of measure (Systolic and diastolic arterial pressures in mmHg were measured per five minutes during the operation)	through study completion, an average of 12 months
Secondary	Oxygen saturation	Differents Units of measure (Oxygen saturation in mmHg was measured per five minutes during the operation)	through study completion, an average of 12 months